0900. Effects of oxygen status on the innate immune response in humans in vivo
© Kiers et al; licensee Springer. 2014
Published: 26 September 2014
In vitro and animal studies have shown that hypoxia and hyperoxia influence the innate immune response. Therefore, hypoxia and hyperoxia could be cheap, non-pharmacological, non-invasive treatment modalities to modulate inflammatory conditions. Hypoxia has shown to exert pro-inflammatory effects, supposedly mediated by the transcription factor hypoxia inducible factor 1α (HIF1α), whereas hyperoxia is related to immune suppression. However, apart from direct effects of oxygen status adjustment on the immune response, other mechanisms such as a hypoxia-induced stress response might play a role in humans in vivo as well. Up till now, the interplay between oxygen status adjustment and the innate immune response in humans in vivo has not been investigated.
To evaluate the effects of hypoxia and hyperoxia on the systemic innate immune responseduring experimental endotoxemia in healthy volunteers.
We performed a parallel randomized controlled study in 30 healthy male volunteers. Using a non-invasive ventilation helmet, subjects were exposed to a total of 3.5 hours of either hypoxia (mixture of nitrogen and room air titrated to an arterial oxygen saturation of 80-85%, n=10), normoxia (room air, n=10), or hyperoxia (100% oxygen, n=10). Actual FiO2 in the helmet was measured using a gas analyzer. One hour after the start of oxygen status adjustment, 2 ng/kg purified E. Coli endotoxinwas administered intravenously.
In contrast with in vitro and animal data, three-and-a-half hours of moderate hypoxia in healthy volunteers attenuates the endotoxin-induced systemic innate immune response, whereas hyperoxia exerts no immunomodulatory effects. The hypoxia-induced immunosuppression is (at least in part) mediated by an increased endogenous adrenaline response. HIF-1α expression increases in circulating leukocytes after endotoxin administration, but is not affected by oxygen status.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.